Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2013

Open Access 01-12-2013 | Research article

The association between the apolipoprotein A1/ high density lipoprotein -cholesterol and diabetes in Taiwan — a cross-sectional study

Authors: Zhi-Hong Jian, Chia-Chi Lung, Pei-Chieh Ko, Yi-Hua Sun, Jing-Yang Huang, Chien-Chang Ho, Chia-Yo Ho, Yi-Chen Chiang, Chien-Jen Chen, Yung-Po Liaw

Published in: BMC Endocrine Disorders | Issue 1/2013

Login to get access

Abstract

Background

Traditional lipid indices have been associated with type 2 diabetes, but it remains uncertain which lipid index is the best discriminator for diabetes. In this study, we aimed to assess lipoproteins, traditional lipid variables, and other variables to discover their association with diabetes in the Taiwanese population.

Methods

Data from a nationwide cross-sectional population-based survey of 3087 men and 3373 women in 2002 were analyzed in this study. All participants were assessed for anthropometry, glycosylated hemoglobin, fasting sugar and lipid profiles with triglycerides, high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol (LDL-C), and apolipoprotein A1 (ApoA1) and B (ApoB). The ratio of LDL-C/HDL-C, ApoB/ApoA1, ApoB/LDL-C and ApoA1/HDL-C and other variables were analyzed to determine their potential roles in type 2 diabetes in the Taiwanese population. The Odds ratios (ORs) of the risk variables for diabetes were estimated using logistic regression and were adjusted for confounding factors.

Results

The increased ratio of ApoA1/HDL-C was significantly associated with diabetes in men (top tertile vs. lowest: OR 2.98; 95% CI: 1.12 - 7.92; P-trend = 0.030) and women (top tertile vs. lowest: OR 2.15; 95% CI: 1.00 - 4.59; P-trend = 0.047). A modest increased diabetic risk was evident with ApoB/LDL-C in women (top tertile vs. lowest: OR 2.03; 95% CI: 1.07- 3.85; P-trend = 0.028), but not in men (top tertile v. lowest: OR 1.69; 95% CI: 0.79- 3.62; P-trend = 0.198).

Conclusions

ApoA1/HDL-C had a significant linear association with diabetes in both sexes and was superior to other lipid and lipoprotein variables among the general Taiwanese population.
Literature
1.
go back to reference Chang CH, Shau WY, Jiang YD, Li HY, Chang TJ, Sheu WH, Kwok CF, Ho LT, Chuang LM: Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999–2004: a national health insurance data set study. Diabet Med. 2010, 27 (6): 636-643. 10.1111/j.1464-5491.2010.03007.x.CrossRefPubMed Chang CH, Shau WY, Jiang YD, Li HY, Chang TJ, Sheu WH, Kwok CF, Ho LT, Chuang LM: Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999–2004: a national health insurance data set study. Diabet Med. 2010, 27 (6): 636-643. 10.1111/j.1464-5491.2010.03007.x.CrossRefPubMed
2.
go back to reference AMERICAN DIABETES ASSOCIATION: Standards of medical care for patients with diabetes mellitus. Diabetes care. 2003, 26 (Suppl 1): S33-S50. AMERICAN DIABETES ASSOCIATION: Standards of medical care for patients with diabetes mellitus. Diabetes care. 2003, 26 (Suppl 1): S33-S50.
3.
go back to reference Luijks H, Schermer T, Bor H, Van Weel C, Lagro-Janssen T, Biermans M, De Grauw W: Prevalence and incidence density rates of chronic comorbidity in type 2 diabetes patients: an exploratory cohort study. BMC Med. 2012, 10: 128-10.1186/1741-7015-10-128.CrossRefPubMedPubMedCentral Luijks H, Schermer T, Bor H, Van Weel C, Lagro-Janssen T, Biermans M, De Grauw W: Prevalence and incidence density rates of chronic comorbidity in type 2 diabetes patients: an exploratory cohort study. BMC Med. 2012, 10: 128-10.1186/1741-7015-10-128.CrossRefPubMedPubMedCentral
4.
go back to reference Collins GS, Mallett S, Omar O, Yu LM: Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med. 2011, 9: 103-10.1186/1741-7015-9-103.CrossRefPubMedPubMedCentral Collins GS, Mallett S, Omar O, Yu LM: Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med. 2011, 9: 103-10.1186/1741-7015-9-103.CrossRefPubMedPubMedCentral
5.
go back to reference Gotto AM: Apolipoproteins and metabolism in atherosclerosis. Trans Am Clin Climatol Assoc. 1990, 101: 46-57. discussion 57–48PubMedPubMedCentral Gotto AM: Apolipoproteins and metabolism in atherosclerosis. Trans Am Clin Climatol Assoc. 1990, 101: 46-57. discussion 57–48PubMedPubMedCentral
6.
go back to reference Onat A, Hergenc G, Bulur S, Ugur M, Kucukdurmaz Z, Can G: The paradox of high apolipoprotein A-I levels independently predicting incident type-2 diabetes among Turks. Int J Cardiol. 2010, 142 (1): 72-79. 10.1016/j.ijcard.2008.12.066.CrossRefPubMed Onat A, Hergenc G, Bulur S, Ugur M, Kucukdurmaz Z, Can G: The paradox of high apolipoprotein A-I levels independently predicting incident type-2 diabetes among Turks. Int J Cardiol. 2010, 142 (1): 72-79. 10.1016/j.ijcard.2008.12.066.CrossRefPubMed
7.
go back to reference Seo MH, Bae JC, Park SE, Rhee EJ, Park CY, Oh KW, Park SW, Kim SW, Lee WY: Association of lipid and lipoprotein profiles with future development of type 2 diabetes in nondiabetic Korean subjects: a 4-year retrospective, longitudinal study. J Clin Endocrinol Metab. 2011, 96 (12): E2050-E2054. 10.1210/jc.2011-1857.CrossRefPubMed Seo MH, Bae JC, Park SE, Rhee EJ, Park CY, Oh KW, Park SW, Kim SW, Lee WY: Association of lipid and lipoprotein profiles with future development of type 2 diabetes in nondiabetic Korean subjects: a 4-year retrospective, longitudinal study. J Clin Endocrinol Metab. 2011, 96 (12): E2050-E2054. 10.1210/jc.2011-1857.CrossRefPubMed
8.
go back to reference Bardini G, Dicembrini I, Rotella CM, Giannini S: Correlation between HDL cholesterol levels and beta-cell function in subjects with various degree of glucose tolerance. Acta diabetol. 2013, 50: 277-281. 10.1007/s00592-011-0339-0.CrossRefPubMed Bardini G, Dicembrini I, Rotella CM, Giannini S: Correlation between HDL cholesterol levels and beta-cell function in subjects with various degree of glucose tolerance. Acta diabetol. 2013, 50: 277-281. 10.1007/s00592-011-0339-0.CrossRefPubMed
9.
go back to reference Sung KC, Hwang ST: Association between insulin resistance and apolipoprotein B in normoglycemic Koreans. Atherosclerosis. 2005, 180 (1): 161-169. 10.1016/j.atherosclerosis.2004.11.009.CrossRefPubMed Sung KC, Hwang ST: Association between insulin resistance and apolipoprotein B in normoglycemic Koreans. Atherosclerosis. 2005, 180 (1): 161-169. 10.1016/j.atherosclerosis.2004.11.009.CrossRefPubMed
10.
go back to reference Ying X, Qian Y, Jiang Y, Jiang Z, Song Z, Zhao C: Association of the apolipoprotein B/apolipoprotein A-I ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity. Acta diabetol. 2012, 49 (6): 465-472. 10.1007/s00592-012-0419-9.CrossRefPubMed Ying X, Qian Y, Jiang Y, Jiang Z, Song Z, Zhao C: Association of the apolipoprotein B/apolipoprotein A-I ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity. Acta diabetol. 2012, 49 (6): 465-472. 10.1007/s00592-012-0419-9.CrossRefPubMed
11.
go back to reference Shih YT HY, Chang HY, Liu JP, Lin HS, Chang MC: The design, contents, operation and the characteristics of the respondents of the 2001 National Health Interview Survey in Taiwan. Taiwan J Public Health. 2004, 22: 419-430. Shih YT HY, Chang HY, Liu JP, Lin HS, Chang MC: The design, contents, operation and the characteristics of the respondents of the 2001 National Health Interview Survey in Taiwan. Taiwan J Public Health. 2004, 22: 419-430.
13.
go back to reference Su TC, Bai CH, Chang HY, You SL, Chien KL, Chen MF, Chen HJ, Pan WH, Tseng CH, Cheng SH: Evidence for improved control of hypertension in Taiwan: 1993–2002. J Hypertens. 2008, 26 (3): 600-606. 10.1097/HJH.0b013e3282f3b352.CrossRefPubMed Su TC, Bai CH, Chang HY, You SL, Chien KL, Chen MF, Chen HJ, Pan WH, Tseng CH, Cheng SH: Evidence for improved control of hypertension in Taiwan: 1993–2002. J Hypertens. 2008, 26 (3): 600-606. 10.1097/HJH.0b013e3282f3b352.CrossRefPubMed
14.
go back to reference World Health Organization: Physical status: the use and interpretation of anthropometry. 1995, Geneva: WHO World Health Organization: Physical status: the use and interpretation of anthropometry. 1995, Geneva: WHO
15.
go back to reference American Diabetes Association: Summary of revisions for the 2010 Clinical Practice Recommendations. Diabetes care. 2010, 33 (Suppl 1): S3- American Diabetes Association: Summary of revisions for the 2010 Clinical Practice Recommendations. Diabetes care. 2010, 33 (Suppl 1): S3-
16.
go back to reference Ginsberg HN: Diabetic dyslipidemia: basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels. Diabetes. 1996, 45 (Suppl 3): S27-30.CrossRefPubMed Ginsberg HN: Diabetic dyslipidemia: basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels. Diabetes. 1996, 45 (Suppl 3): S27-30.CrossRefPubMed
17.
go back to reference Ley SH, Harris SB, Connelly PW, Mamakeesick M, Gittelsohn J, Wolever TM, Hegele RA, Zinman B, Hanley AJ: Utility of non-high-density lipoprotein cholesterol in assessing incident type 2 diabetes risk. Diabetes Obes Metab. 2012, 14 (9): 821-825. 10.1111/j.1463-1326.2012.01607.x.CrossRefPubMed Ley SH, Harris SB, Connelly PW, Mamakeesick M, Gittelsohn J, Wolever TM, Hegele RA, Zinman B, Hanley AJ: Utility of non-high-density lipoprotein cholesterol in assessing incident type 2 diabetes risk. Diabetes Obes Metab. 2012, 14 (9): 821-825. 10.1111/j.1463-1326.2012.01607.x.CrossRefPubMed
18.
go back to reference Ley SH, Harris SB, Connelly PW, Mamakeesick M, Gittelsohn J, Wolever TM, Hegele RA, Zinman B, Hanley AJ: Association of apolipoprotein B with incident type 2 diabetes in an aboriginal Canadian population. Clin Chem. 2010, 56 (4): 666-670. 10.1373/clinchem.2009.136994.CrossRefPubMed Ley SH, Harris SB, Connelly PW, Mamakeesick M, Gittelsohn J, Wolever TM, Hegele RA, Zinman B, Hanley AJ: Association of apolipoprotein B with incident type 2 diabetes in an aboriginal Canadian population. Clin Chem. 2010, 56 (4): 666-670. 10.1373/clinchem.2009.136994.CrossRefPubMed
19.
go back to reference Belfki H, Ben Ali S, Bougatef S, Ben Ahmed D, Haddad N, Jmal A, Abdennebi M, Ben Romdhane H: The Apolipoprotein B/Apolipoprotein A 1 ratio in relation to metabolic syndrome and its components in a sample of the Tunisian population. Exp Mol Pathol. 2011, 91 (2): 622-625. 10.1016/j.yexmp.2011.06.007.CrossRefPubMed Belfki H, Ben Ali S, Bougatef S, Ben Ahmed D, Haddad N, Jmal A, Abdennebi M, Ben Romdhane H: The Apolipoprotein B/Apolipoprotein A 1 ratio in relation to metabolic syndrome and its components in a sample of the Tunisian population. Exp Mol Pathol. 2011, 91 (2): 622-625. 10.1016/j.yexmp.2011.06.007.CrossRefPubMed
20.
go back to reference Krauss RM: Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Curr Opin Lipidol. 1994, 5 (5): 339-349. 10.1097/00041433-199410000-00005.CrossRefPubMed Krauss RM: Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Curr Opin Lipidol. 1994, 5 (5): 339-349. 10.1097/00041433-199410000-00005.CrossRefPubMed
21.
go back to reference Goldberg IJ: Clinical review 124: Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab. 2001, 86 (3): 965-971. 10.1210/jc.86.3.965.CrossRefPubMed Goldberg IJ: Clinical review 124: Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab. 2001, 86 (3): 965-971. 10.1210/jc.86.3.965.CrossRefPubMed
22.
go back to reference Caixas A, Ordonez-Llanos J, De Leiva A, Payes A, Homs R, Perez A: Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients. Diabetes. 1997, 46 (7): 1207-1213. 10.2337/diab.46.7.1207.CrossRefPubMed Caixas A, Ordonez-Llanos J, De Leiva A, Payes A, Homs R, Perez A: Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients. Diabetes. 1997, 46 (7): 1207-1213. 10.2337/diab.46.7.1207.CrossRefPubMed
23.
go back to reference Mykkanen L, Kuusisto J, Haffner SM, Laakso M, Austin MA: LDL size and risk of coronary heart disease in elderly men and women. Arterioscler Thromb Vasc Biol. 1999, 19 (11): 2742-2748. 10.1161/01.ATV.19.11.2742.CrossRefPubMed Mykkanen L, Kuusisto J, Haffner SM, Laakso M, Austin MA: LDL size and risk of coronary heart disease in elderly men and women. Arterioscler Thromb Vasc Biol. 1999, 19 (11): 2742-2748. 10.1161/01.ATV.19.11.2742.CrossRefPubMed
24.
go back to reference Abate N, Vega GL, Garg A, Grundy SM: Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM. Atherosclerosis. 1995, 118 (1): 111-122. 10.1016/0021-9150(95)05597-P.CrossRefPubMed Abate N, Vega GL, Garg A, Grundy SM: Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM. Atherosclerosis. 1995, 118 (1): 111-122. 10.1016/0021-9150(95)05597-P.CrossRefPubMed
25.
go back to reference Haffner SM, Mykkanen L, Festa A, Burke JP, Stern MP: Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation. 2000, 101 (9): 975-980. 10.1161/01.CIR.101.9.975.CrossRefPubMed Haffner SM, Mykkanen L, Festa A, Burke JP, Stern MP: Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation. 2000, 101 (9): 975-980. 10.1161/01.CIR.101.9.975.CrossRefPubMed
26.
go back to reference Laws A, Hoen HM, Selby JV, Saad MF, Haffner SM, Howard BV: Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Arterioscler Thromb Vasc Biol. 1997, 17 (1): 64-71. 10.1161/01.ATV.17.1.64.CrossRefPubMed Laws A, Hoen HM, Selby JV, Saad MF, Haffner SM, Howard BV: Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Arterioscler Thromb Vasc Biol. 1997, 17 (1): 64-71. 10.1161/01.ATV.17.1.64.CrossRefPubMed
27.
go back to reference Al-Bahrani AI, Bakhiet CS, Bayoumi RA, Al-Yahyaee SA: A potential role of apolipoprotein B in the risk stratification of diabetic patients with dyslipidaemia. Diabetes Res Clin Pract. 2005, 69 (1): 44-51. 10.1016/j.diabres.2004.09.011.CrossRefPubMed Al-Bahrani AI, Bakhiet CS, Bayoumi RA, Al-Yahyaee SA: A potential role of apolipoprotein B in the risk stratification of diabetic patients with dyslipidaemia. Diabetes Res Clin Pract. 2005, 69 (1): 44-51. 10.1016/j.diabres.2004.09.011.CrossRefPubMed
28.
go back to reference Wagner AM, Jorba O, Rigla M, Alonso E, Ordonez-Llanos J, Perez A: LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes. Acta Diabetol. 2002, 39 (4): 215-220. 10.1007/s005920200037.CrossRefPubMed Wagner AM, Jorba O, Rigla M, Alonso E, Ordonez-Llanos J, Perez A: LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes. Acta Diabetol. 2002, 39 (4): 215-220. 10.1007/s005920200037.CrossRefPubMed
29.
go back to reference Onat A, Can G, Cicek G, Ayhan E, Dogan Y: Predictive value of serum apolipoprotein B/LDL-cholesterol ratio in cardiometabolic risk: population-based cohort study. Clin Biochem. 2010, 43 (18): 1381-1386. 10.1016/j.clinbiochem.2010.08.027.CrossRefPubMed Onat A, Can G, Cicek G, Ayhan E, Dogan Y: Predictive value of serum apolipoprotein B/LDL-cholesterol ratio in cardiometabolic risk: population-based cohort study. Clin Biochem. 2010, 43 (18): 1381-1386. 10.1016/j.clinbiochem.2010.08.027.CrossRefPubMed
30.
go back to reference Fielding CJ, Fielding PE: Molecular physiology of reverse cholesterol transport. J Lipid Res. 1995, 36 (2): 211-228.PubMed Fielding CJ, Fielding PE: Molecular physiology of reverse cholesterol transport. J Lipid Res. 1995, 36 (2): 211-228.PubMed
31.
go back to reference Miller NE, Thelle DS, Forde OH, Mjos OD: The Tromso heart-study. High-density lipoprotein and coronary heart-disease: a prospective case–control study. Lancet. 1977, 1 (8019): 965-968.CrossRefPubMed Miller NE, Thelle DS, Forde OH, Mjos OD: The Tromso heart-study. High-density lipoprotein and coronary heart-disease: a prospective case–control study. Lancet. 1977, 1 (8019): 965-968.CrossRefPubMed
32.
go back to reference Koropatnick TA, Kimbell J, Chen R, Grove JS, Donlon TA, Masaki KH, Rodriguez BL, Willcox BJ, Yano K, Curb JD: A prospective study of high-density lipoprotein cholesterol, cholesteryl ester transfer protein gene variants, and healthy aging in very old Japanese-american men. J Gerontol A Biol Sci Med Sci. 2008, 63 (11): 1235-1240. 10.1093/gerona/63.11.1235.CrossRefPubMed Koropatnick TA, Kimbell J, Chen R, Grove JS, Donlon TA, Masaki KH, Rodriguez BL, Willcox BJ, Yano K, Curb JD: A prospective study of high-density lipoprotein cholesterol, cholesteryl ester transfer protein gene variants, and healthy aging in very old Japanese-american men. J Gerontol A Biol Sci Med Sci. 2008, 63 (11): 1235-1240. 10.1093/gerona/63.11.1235.CrossRefPubMed
33.
go back to reference Brunzell JD, Sniderman AD, Albers JJ, Kwiterovich PO: Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis. 1984, 4 (2): 79-83. 10.1161/01.ATV.4.2.79.CrossRefPubMed Brunzell JD, Sniderman AD, Albers JJ, Kwiterovich PO: Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis. 1984, 4 (2): 79-83. 10.1161/01.ATV.4.2.79.CrossRefPubMed
34.
go back to reference Toth PP, Davidson MH: High-density lipoproteins: marker of cardiovascular risk and therapeutic target. J Clin Lipidol. 2010, 4 (5): 359-364. 10.1016/j.jacl.2010.08.002.CrossRefPubMed Toth PP, Davidson MH: High-density lipoproteins: marker of cardiovascular risk and therapeutic target. J Clin Lipidol. 2010, 4 (5): 359-364. 10.1016/j.jacl.2010.08.002.CrossRefPubMed
35.
go back to reference Nobecourt E, Tabet F, Lambert G, Puranik R, Bao S, Yan L, Davies MJ, Brown BE, Jenkins AJ, Dusting GJ: Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I. Arterioscler Thromb Vasc Biol. 2010, 30 (4): 766-772. 10.1161/ATVBAHA.109.201715.CrossRefPubMedPubMedCentral Nobecourt E, Tabet F, Lambert G, Puranik R, Bao S, Yan L, Davies MJ, Brown BE, Jenkins AJ, Dusting GJ: Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I. Arterioscler Thromb Vasc Biol. 2010, 30 (4): 766-772. 10.1161/ATVBAHA.109.201715.CrossRefPubMedPubMedCentral
36.
go back to reference Park KH, Shin DG, Kim JR, Hong JH, Cho KH: The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity. Int J Mol Med. 2010, 25 (1): 129-136.PubMed Park KH, Shin DG, Kim JR, Hong JH, Cho KH: The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity. Int J Mol Med. 2010, 25 (1): 129-136.PubMed
37.
go back to reference Schreier LE, Berg GA, Basilio FM, Lopez GI, Etkin AE, Wikinski RL: Lipoprotein alterations, abdominal fat distribution and breast cancer. Biochem Mol Biol Int. 1999, 47 (4): 681-690.PubMed Schreier LE, Berg GA, Basilio FM, Lopez GI, Etkin AE, Wikinski RL: Lipoprotein alterations, abdominal fat distribution and breast cancer. Biochem Mol Biol Int. 1999, 47 (4): 681-690.PubMed
38.
go back to reference Bray GA, Jablonski KA, Fujimoto WY, Barrett-Connor E, Haffner S, Hanson RL, Hill JO, Hubbard V, Kriska A, Stamm E: Relation of central adiposity and body mass index to the development of diabetes in the diabetes prevention program. Am J Clin Nutr. 2008, 87 (5): 1212-1218.PubMedPubMedCentral Bray GA, Jablonski KA, Fujimoto WY, Barrett-Connor E, Haffner S, Hanson RL, Hill JO, Hubbard V, Kriska A, Stamm E: Relation of central adiposity and body mass index to the development of diabetes in the diabetes prevention program. Am J Clin Nutr. 2008, 87 (5): 1212-1218.PubMedPubMedCentral
39.
go back to reference Chien LY, Liou YM, Chen JJ: Association between indices of obesity and fasting hyperglycemia in Taiwan. Int J Obes Relat Metab Disord. 2004, 28 (5): 690-696. 10.1038/sj.ijo.0802619.CrossRefPubMed Chien LY, Liou YM, Chen JJ: Association between indices of obesity and fasting hyperglycemia in Taiwan. Int J Obes Relat Metab Disord. 2004, 28 (5): 690-696. 10.1038/sj.ijo.0802619.CrossRefPubMed
40.
go back to reference Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, Farzaneh-Far R, Grundy SM, Khera A, McGuire DK, De Lemos JA: Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA. 2012, 308 (11): 1150-1159. 10.1001/2012.jama.11132.CrossRefPubMedPubMedCentral Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, Farzaneh-Far R, Grundy SM, Khera A, McGuire DK, De Lemos JA: Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA. 2012, 308 (11): 1150-1159. 10.1001/2012.jama.11132.CrossRefPubMedPubMedCentral
41.
go back to reference Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, Rimm E, Colditz GA: Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001, 161 (13): 1581-1586. 10.1001/archinte.161.13.1581.CrossRefPubMed Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, Rimm E, Colditz GA: Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001, 161 (13): 1581-1586. 10.1001/archinte.161.13.1581.CrossRefPubMed
42.
go back to reference Cheng CH, Ho CC, Yang CF, Huang YC, Lai CH, Liaw YP: Waist-to-hip ratio is a better anthropometric index than body mass index for predicting the risk of type 2 diabetes in Taiwanese population. Nutr Res. 2010, 30 (9): 585-593. 10.1016/j.nutres.2010.08.007.CrossRefPubMed Cheng CH, Ho CC, Yang CF, Huang YC, Lai CH, Liaw YP: Waist-to-hip ratio is a better anthropometric index than body mass index for predicting the risk of type 2 diabetes in Taiwanese population. Nutr Res. 2010, 30 (9): 585-593. 10.1016/j.nutres.2010.08.007.CrossRefPubMed
43.
go back to reference Chen CC, Wang WS, Chang HY, Liu JS, Chen YJ: Heterogeneity of body mass index, waist circumference, and waist-to-hip ratio in predicting obesity-related metabolic disorders for Taiwanese aged 35–64 y. Clin Nutr. 2009, 28 (5): 543-548. 10.1016/j.clnu.2009.04.017.CrossRefPubMed Chen CC, Wang WS, Chang HY, Liu JS, Chen YJ: Heterogeneity of body mass index, waist circumference, and waist-to-hip ratio in predicting obesity-related metabolic disorders for Taiwanese aged 35–64 y. Clin Nutr. 2009, 28 (5): 543-548. 10.1016/j.clnu.2009.04.017.CrossRefPubMed
Metadata
Title
The association between the apolipoprotein A1/ high density lipoprotein -cholesterol and diabetes in Taiwan — a cross-sectional study
Authors
Zhi-Hong Jian
Chia-Chi Lung
Pei-Chieh Ko
Yi-Hua Sun
Jing-Yang Huang
Chien-Chang Ho
Chia-Yo Ho
Yi-Chen Chiang
Chien-Jen Chen
Yung-Po Liaw
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2013
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/1472-6823-13-42

Other articles of this Issue 1/2013

BMC Endocrine Disorders 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.